Anzeige
Mehr »
Login
Freitag, 24.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CRZG | ISIN: US2861761029 | Ticker-Symbol:
Branche
Fahrzeuge
Aktienmarkt
Sonstige
1-Jahres-Chart
ELEKTROS INC Chart 1 Jahr
5-Tage-Chart
ELEKTROS INC 5-Tage-Chart
ACCESS Newswire
183 Leser
Artikel bewerten:
(1)

Elektros, Inc.: Elektros Launches Evaluation of High-Performance GPU Technology for Compact, Private AI Data Centers

Finanznachrichten News

SUNNY ISLES BEACH, FL / ACCESS Newswire / January 24, 2025 / Elektros (OTC PINK:ELEK) ("Elektros" or "the Company"), a pioneer in sustainable energy solutions, begins review of advanced GPU equipment and services for domain specific, private AI data centers.

This strategic move aligns with the recent STARGATE initiative announced by the Trump administration, emphasizing the critical need for expanded AI capabilities across the United States.

While STARGATE represents a monumental, capital-intensive project aimed at bolstering national AI capabilities, Elektros is charting a complementary course by developing significantly smaller, more focused, and cost-effective AI infrastructure solutions.

At the helm of this ambitious initiative is Next Realm AI, serving as the lead project manager and strategic advisor. Elektros has partnered with Next Realm AI to leverage their unparalleled expertise in AI data center development, Large Language Models (LLMs), Small Language Models (SLMs), and AI Agents. Next Realm AI understanding of AI infrastructure needs will play a pivotal role in shaping the project's direction.

Key aspects of the initiative include:

  • Deployment of cutting-edge GPU equipment for small-scale, high-performance AI data centers

  • Customized AI services tailored for specific domain applications

  • Implementation of energy-efficient solutions to address the growing power demands of AI infrastructure

  • Utilization of Elektros' lithium supply chain to support sustainable energy storage solutions

Elektros is currently evaluating state-of-the-art hardware solutions to power these next-generation AI data centers:

  1. AMD Instinct MI300X: This powerhouse GPU is being considered for its exceptional performance in generative AI and High-Performance Computing (HPC) workloads. The MI300X's superior visual rendering capabilities make it ideal for complex simulations and 3D modeling tasks, perfectly aligning with the diverse needs of AI applications.

  2. Dual EPYC Genoa 8x NVIDIA H200 GPU Server: This high-density server configuration is under review for its potential to deliver unprecedented computational power in a compact form factor. The combination of AMD's EPYC processors and NVIDIA's latest H200 GPUs promises to offer the perfect balance of performance and efficiency for AI workloads.

Tom Bustamante, Founder and CEO of Next Realm AI commented, "The integration of these advanced GPU solutions into the project roadmap will enable Elektros to offer unparalleled performance for a wide range of AI applications. From generative AI to complex simulations, the company would be able to provide businesses with the tools they need to push the boundaries of innovation, and automation."

This initiative also underscores Elektros' commitment to addressing the escalating energy demands of AI infrastructure, recognizing that power consumption will become a critical bottleneck for AI data centers. By leveraging its expertise in lithium supply and energy storage solutions, Elektros is uniquely positioned to offer renewable energy solutions through advanced battery energy storage systems (BESS). These systems will not only power Elektros' own data center operations but also be made available to other businesses across Florida and the United States.

Join our Elektros Investor Network at https://elektros.energy/investors/

About Next Realm AI
Next Realm AI is a cutting-edge technology research and consulting firm based in New York City, specializing in the commercial development of next-generation technologies. artificial intelligence, data analytics, quantum computing, and cybersecurity, with particular expertise in developing Small Language Models (SLMs) and AI Agents for specific industries, while assisting enterprises in integrating advanced technologies, automation, data security, and quantum computing solutions. We aim to drive technological advancements that shape the future while addressing pressing global issues. www.nextrealm.ai

About Elektros, Inc.
Elektros (OTC PINK:ELEK) is a vertically integrated sustainable energy company focused on lithium mining, electric vehicle charging, solar energy storage, and power supply for AI data centers. We are at the forefront of the clean energy transition, driving innovation in mobility and energy technologies to combat the global climate crisis and deliver transformative user experiences. www.elektros.energy

Follow on Facebook: https://www.facebook.com/Elektrosenergy

Cautionary Language Concerning Forward-Looking Statements
This release contains "forward-looking statements" that include information relating to future events and future financial and operating performance. The words "may," "would," "will," "expect," "estimate," "can," "believe," "potential," and similar expressions and variations thereof are intended to identify forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management's good faith belief as of that time with respect to future events and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Important factors that could cause these differences include, but are not limited to: fluctuations in demand for Elektros, Inc.'s products, the introduction of new products, the Company's ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company's liquidity and financial strength to support its growth, and other information that may be detailed from time to time in Elektros Inc.'s filings with the United States Securities and Exchange Commission. Examples of such forward-looking statements in this release include statements regarding future sales, costs, and market acceptance of products as well as regulatory actions at the State or Federal level. For a more detailed description of the risk factors and uncertainties affecting Elektros Inc., please refer to the Company's Securities and Exchange Commission filings, which are available at www.sec.gov. Elektros, Inc. undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

CONTACT:
Elektros, Inc.
IR and Media Inquiries
Email: ElektrosInc@gmail.com

AI Venturetech
Phone: (917) 746-8054
Email: info@elektros.energ

SOURCE: Elektros, Inc.



View the original press release on ACCESS Newswire

© 2025 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.